Graduate, postgraduate and Masters degree Lectures and Tutorial 

​

Specialist Care of the Older Persons Essentials Course (SCOPE) Ophthalmology {Masters level course } ongoing

• This course is being accredited by Northampton University at Masters level.

• This is intensive course for registered nurses and allied healthcare professionals that work with older patients and are passionate about improving their care.

• Speaker: Mr. Allaaeldin Abumattar (Consultant Ophthalmic Surgeon).

​

Advanced Adult Assessment and Examination (AAAE) module {Masters level course } ongoing

• This module is appropriate to develop and enhance skills of physical assessment in a systematic way including Ophthalmology.

• This is the result of collaboration between GWGFT Academy and University of Northampton to develop an Advanced Adult Assessment and Examination (AAAE) module that will be nationally recognised by universities across the UK.

• Speaker: Mr. Allaaeldin Abumattar (Consultant Ophthalmic Surgeon).

​

The Aging Eye ​ongoing

• Swindon GP Education Trust - Ophthalmology Course​.

• Relevant Curriculum Statement: 3.16 - Care of people with eye problems.

• Speaker: Mr. Allaaeldin Abumattar (Consultant Ophthalmic Surgeon).

• Objectives:

  • Enhance knowledge of common or important eye conditions & their management

  • Summarise some useful top tips for ophthalmology in primary care

  • Learn more about how to make the best use of secondary care & other services available

​

Ophthalmology tutorials for 3rd year medical students (topic/s taught depends on the curriculum at the time ) ongoing

• Assessment and Examination Skills in Ophthalmology,​

• Sudden and gradual loss of vision,

• The red eye, 

• Neuro-ophthalmology.

​

Publications (authored and co-authored)

​

Simplified Thyroid Eye Disease Grading Proforma. 

BOPSS 2014 Annual Meeting St George’s Hall, Liverpool The British Oculoplastic Surgery Society (BOPPS) Scientific Meeting was held on 12th – 13th June

​

Two year outcomes of the integrated management scheme for Age-related Macular Degeneration (AMD) clinics and patient feedback with Eylea Treatment Protocol

AMD treatment, The Swindon Model (ARVO 2019).

​

Exploring options in AMD treatment:

Results of a 12-month treatment regime with bimonthly aflibercept injections (oxford congress 2019).

​

​Results of a 12-month fixed-dose aflibercept treatment protocol

EURETINA 2019

​

Morphologic characteristics, ultrasound backscatter and prognosis of uveal  melanoma in Wiltshire​

1st UK Ocular Oncology Conference (UKOO 2019)

​

AMD treatment past and present:

Comparison of PRN Ranibizumab versus fixed dose Aflibercept protocols, year 1 outcomes (RCOphth. congress 2018).

​

Audits and Studies

​

OZURDEX A real life clinical practice study 2015

Objective: To evaluate the effectiveness of dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan, Inc., Irvine, CA).

Enrolment: Retrospective review was performed on the clinical records of 34 patients treated with intravitreal dexamethasone (Ozurdex®, Allergan) in SMH by Mr. Abumattar.

​

Pain scores following Intravitreal injection 2013

Purpose: To evaluate needle pain score following intravitreal injection.

Enrolment: 81 patients attending Stoke Mandeville Hospital day case clean room for injection.

Conclusions: 

• Intravitreal injection pain is mild and not as feared .

• Allow adequate time for anaesthetic drops to take effect. 

• Topical anaesthesia is safe, quick, and cost-effective.

• Proxymetacaine is a preferable topical drop.  

• Addressing the patient's injection-related concerns, listening to them, reduce their anxiety and minimise their pain.

​

 Cost of Last Minute Cancellations (LMC) in Ophthalmology to the Trust

Purpose: find out what is Cost of Cancellation of operations on the day of intended surgery” 2012 / 2013 to the trust?

Aim of the Study:  

• Define the extent of Ophthalmology LMCs problem!

• Cost of ophthalmology LMCs to the Trust?

• Ascertain reasons for LMCs, and suggest recommendations to reduce them as this will have direct effect on the waiting list.

​

Botulinum toxin treatments in Wycombe Hospital patients

Design of the study: This was a retrospective observational study to assess the subjective patient benefit of Botulinum toxin treatments for Blepharospasm. Jankovic clinical grading of severity of spasm was used.

Results:

• 89.5% of patients experienced an improvement in symptoms. Other studies report improvements in symptoms in 85–95% of patients.

• ⋝15.7% of patients needed more than one initial visit to control the spasm.

• Ptosis was experienced in more than half of patients (other studies 58% mild +6.7% marked). This is important when counselling patients, especially Ptosis may prevent them from driving

​

​Are we fulfilling our promise? Wycombe cataract patients

Burnham Prime eye care Audit 

Causes of Cancellation of ophthalmology cases on the Day of Surgery 

Cataract audit at Ayr Hospital 2003 Teaching and Training

 Occupational Burnout / satisfaction questionnaire 2015

​

Clinical Trials

​

ECHoES clinical trial 

• Mr. Abumattar participated as a hospital ophthalmologist in this study.

• PROJECT TITLE: The effectiveness of Community vs. Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration (nAMD) with quiescent disease: a virtual trial. (The ECHoES trial)

• DESIGN: ECHoES is a virtual trial of ophthalmologists and optometrists decisions about the need for anti-VEGF retreatment in patients with nAMD. It is based on vignettes consisting of colour fundus and optical coherence tomography (OCT) images with accompanying clinical data. Vignettes created using information collected in a national comparative effectiveness trial of anti-VEGF drugs (the IVAN study), to mimic the characteristics of patients judged to be eligible for follow up in the community. Both groups will assess the same vignettes, viewing images and data and submitting their decisions via the internet.

• SETTING: Ophthalmologists decisions will represent the Hospital Eye Service (HES). Optometrists decisions will represent the community / primary care setting.

• CONCLUSIONS: Optometrists' ability to make nAMD retreatment decisions from vignettes is not inferior to ophthalmologists' ability. Shared care with optometrists monitoring quiescent nAMD lesions has the potential to reduce workload in hospitals

• PUBLICATION DATE: The main results paper for the ECHoES study published in the Eye online 9 October 2015 2)

​

Safety and Efficacy of Bimatoprost to Treat Hypotrichosis of the Eyelashes after Application clinical trial

• Mr. Abumattar worked as a sub investigator in this study

• This one-year study evaluates the long-term safety and effectiveness of Bimatoprost solution application to the eyelid margin to treat Hypotrichosis of the eyelashes. There were two different types of subjects participating in the study 1) Those with inadequate eyelashes due to natural causes or 2) Those with inadequate eyelashes following a complete course of chemotherapy treatment. There were two treatment periods of six months each. Subjects received either the study medication or vehicle in either of the two treatment periods. We had 368 subjects enrolled into the study, 334 subjects have completed their month 6 visit, and 142 subjects have completed their month 12 visit.

• Study type Interventional, Treatment, Randomized, Double Blind (Subject, Investigator, Outcomes Assessor), Parallel Assignment, Safety/Efficacy Study

• PRIMARY OUTCOME MEASURE: Percentage of Treatment Responders RESULTS: A higher percentage of subjects treated with bimatoprost 0.03% (78.1%) versus vehicle (18.4%) demonstrated at least a 1-grade increase in global eyelash assessment score at week 16 (P < .0001). Subjects in the bimatoprost 0.03% group also had statistically significantly greater increases in eyelash length, thickness, and darkness (P < .0001) than those in the vehicle group. For adverse events, only conjunctival hyperemia occurred at a statistically significant higher incidence rate in the bimatoprost 0.03% versus the vehicle group (P = .03).

• CONCLUSION: Bimatoprost 0.03% was found to be effective at enhancing eyelashes in adults with a very good safety profile.

​

​